<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01159470</url>
  </required_header>
  <id_info>
    <org_study_id>472010.ctil</org_study_id>
    <nct_id>NCT01159470</nct_id>
  </id_info>
  <brief_title>The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children</brief_title>
  <acronym>CRPv</acronym>
  <official_title>CRP Velocity as a Marker for Bacterial Infections in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fever is one of the most common problems in pediatrics. Differentiating between bacterial&#xD;
      infections, that require antibiotic therapy, and viral infections that resolve on their own&#xD;
      is an important challenge for physicians.&#xD;
&#xD;
      C-reactive protein (CRP) is a protein that increases in response to inflammation and its&#xD;
      level is generally higher in bacterial infections compared to viral infections. it can be&#xD;
      measured by a simple blood test, however its utility as a sole marker for bacterial infection&#xD;
      is limited.&#xD;
&#xD;
      The hypothesis of the study is that measuring CRP velocity, e.g the value of CRP divided by&#xD;
      the hours since the fever started will improve the utility of CRP for the diagnosis of&#xD;
      bacterial infections in children.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bacterial Infections</condition>
  <condition>Viral Infection</condition>
  <arm_group>
    <arm_group_label>bacterial infection</arm_group_label>
    <description>children with fever due to bacterial infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>viral infection</arm_group_label>
    <description>children with fever due to viral infection</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        children &lt; 5 years of age presenting to the Emergency Department with fever&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children less than 5 years of age,&#xD;
&#xD;
          -  children with no comorbidities and fever &gt; 38 for at least 24 hours, and&#xD;
&#xD;
          -  children with no previous antibiotic therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HIV,&#xD;
&#xD;
          -  immunosuppressive conditions,&#xD;
&#xD;
          -  antibiotic therapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2010</verification_date>
  <study_first_submitted>July 8, 2010</study_first_submitted>
  <study_first_submitted_qc>July 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2010</study_first_posted>
  <last_update_submitted>July 8, 2010</last_update_submitted>
  <last_update_submitted_qc>July 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Maskit Bar-Meir, MD</name_title>
    <organization>Shaare-Zedek Medical Center</organization>
  </responsible_party>
  <keyword>CRP velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

